Evaluation of carotid intima-media thickness and cardiovascular risk factors in benign prostatic hyperplasia patients

Parag Jaipuriya 1, Arun Sekar 2, Ershad Hussain Galeti 3 * , Vedamurthy Reddy Pogula 4, Gousia Begum 5
More Detail
1 Department of Urology, United Hospital, Gondia, Maharashtra, India
2 Department of Anaesthesiology, Government Mohan Kumaramangalam Medical College, Salem, Tamilnadu, India
3 Department of General Surgery and Urology, Viswabharathi Medical College, Kurnool, Andhra Pradesh, India
4 Department of Urology, Narayana Medical College, Nellore, India
5 Department of Anaesthesia, Viswabharathi Medical College, Kurnool, Andhra Pradesh, India
* Corresponding Author
J CLIN MED KAZ, Volume 20, Issue 3, pp. 49-55. https://doi.org/10.23950/jcmk/13321
OPEN ACCESS 467 Views 332 Downloads
Download Full Text (PDF)

ABSTRACT

Objective: To assess the carotid intima-media thickness and cardiovascular risk factors in patients with benign prostatic hyperplasia.
Material and methods: This was a prospective observational study conducted over two years in 100 patients who presented with benign prostatic hyperplasia (BPH). IPSS questionnaire was used to evaluate the symptomatology of BPH. Patients were examined for cardiovascular risk factors. All patients underwent echocardiographic examination for left ventricular function. A single experienced sonographer, blinded to all clinical information, assessed the common carotid artery. 
Results: The patients mean age was 69.32 years. The mean BMI was 28.91 kg/m². Of the total mild symptom score cases, 75 % (N=6) cases had Grade I prostatomegaly (26 – 40 cc). 98.38 % (N=61) cases had Grade II prostatomegaly (41 – 60 cc), 93.33 % (N=28) cases had Grade III prostatomegaly (>60cc). A mean carotid intima-media thickness (IMT) of 0.56 mm was found in cases having mild IPSS scores (Score 1-7), 0.73 mm was found in cases having moderate IPSS score (Score 8-19), 0.92 mm was found in cases having severe IPSS scores (Score 20-35). Significant association was present between mean BMI, diabetes mellitus, hypertension, hyperlipidemia, smoking and mean Carotid IMT with IPSS as p-value was <0.05. Significant association was present between total cholesterol, HDL, LDL and prostate volume with p-value <0.0001.
Conclusion: This study found that prostatic tissue had a strong relationship with carotid IMT and cardiovascular risk factors in BPH patients. These data suggest a possible link between carotid IMT and cardiovascular risk factors and BPH.
Keywords: benign prostate hyperplasia, carotid, diabetes mellitus, hypertension, intima-media thickness, sonography

CITATION

Jaipuriya P, Sekar A, Galeti EH, Pogula VR, Begum G. Evaluation of carotid intima-media thickness and cardiovascular risk factors in benign prostatic hyperplasia patients. J CLIN MED KAZ. 2023;20(3):49-55. https://doi.org/10.23950/jcmk/13321

REFERENCES

  • Shabbir, Majid, and Faiz H Mumtaz. Benign prostatic hyperplasia. The journal of the Royal Society for the Promotion of Health. 2004; 124(5):222-7. https://doi.org/10.1177/146642400412400519
  • Montie, J E, and K J Pienta. Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. Urology. 1994; 43(6):892-9. https://doi.org/10.1016/0090-4295(94)90163-5
  • Carmena, Rafael. Type 2 diabetes, dyslipidemia, and vascular risk: rationale and evidence for correcting the lipid imbalance. American heart journal. 2005; 150(5):859-70. https://doi.org/10.1016/j.ahj.2005.04.027
  • Parsons, J Kellogg et al. Lipids, lipoproteins and the risk of benign prostatic hyperplasia in community-dwelling men. BJU international. 2008; 101(3):313-8. https://doi.org/10.1111/j.1464-410X.2007.07332.x
  • Resnick, M. I. Clinical urography (2nd ed) PollackH.M. and McClennanB.L.: Clinical Urography p. 2001. W. B. Saunders Company. Journal of Urology. 2000;165(4):1385-50. https://doi.org/10.1016/S0022-5347(01)69904-X
  • Parker, W. H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertility and Sterility. 2007; 87(4):725-736. https://doi.org/10.1016/j.fertnstert.2007.01.093
  • Nasir S, Tulin Y, Cenk S, et al. Evaluation of cardiovascular risk factors in women with uterine Leimyomata: is there a link with atherosclerosis? Balk Med J. 2012; https://doi.org/10.5152/balkanmedj.2012.002
  • Luoto R, Kaprio J, Reunanen A, Rutanen EM. Cardiovascular morbidity in relation to ovarian function after hysterectomy. Obstet Gynecol. 1995;85(4):515-522. https://doi.org/10.1016/0029-7844(94)00456-N
  • Silver MA, Raghuvir R, Fedirko B, Elser D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich). 2005; 7(11):664-668. https://doi.org/10.1111/j.1524-6175.2005.04384.x
  • Aksoy Y, Sivri N, Karaoz B, Sayin C, Yetkin E. Carotid intima-media thickness: a new marker of patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol. 2014;175:54-57. https://doi.org/10.1016/j.ejogrb.2014.01.005
  • Lee KC, Weiss JP. Chapter 5. Diagnosis, Assessment, and Examination, Nocturia. Academic Press. ISBN 9780128200971; 2020; 41-69. https://doi.org/10.1016/B978-0-12-820097-1.00005-6
  • Hammarsten J, Högstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol. 2001; 39(2):151-158. https://doi.org/10.1159/000052430
  • Gachchi TN, Hanumegowda RK, Sundar J, Rammaiah K, Siddaiah MC. Comparison of prostate volume measured by transabdominal ultrasound and transrectal ultrasound in patient with LUTS due to benign prostatic enlargement. J Evid Based Med Healthc. 2017;4(45):2748-2754. https://doi.org/10.18410/jebmh/2017/546
  • Michel MC, Heemann U, Schumacher H, Mehlburger L, Goepel M. Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol. 2004; 172(4 Pt 1):1390-1393. https://doi.org/10.1097/01.ju.0000139995.85780.d8
  • Berger AP, Bartsch G, Deibl M, et al. Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int. 2006; 98(5):1038-1042. https://doi.org/10.1111/j.1464-410X.2006.06400.x
  • Hammarsten J, Högstedt B, Holthuis N, Mellström D. Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis. 1998; 1(3):157-162. https://doi.org/10.1038/sj.pcan.4500221
  • St Sauver JL, Jacobsen SJ, Jacobson DJ, et al. Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU Int. 2011;107(3):443-450. https://doi.org/10.1111/j.1464-410X.2010.09598.x
  • Nickel JC. Role of prostatic inflammation in the clinical presentation of benign prostatic hyperplasia. Eur Urol Suppl. 2015;14(9):e1459-e1463. https://doi.org/10.1016/S1569-9056(15)30500-5
  • Pinto AMA, González MS. Endourology and Benign Prostatic Hyperplasia in COVID-19 Pandemic. Int Braz J Urol. 2020;46(suppl.1):34-38. https://doi.org/10.1590/s1677-5538.ibju.2020.s104
  • Awaisu M, Ahmed M, Lawal AT, et al. Correlation of prostate volume with severity of lower urinary tract symptoms as measured by international prostate symptoms score and maximum urine flow rate among patients with benign prostatic hyperplasia. Afr J Urol. 2021; 27(1). https://doi.org/10.1186/s12301-021-00122-4
  • Yelsel K, Alma E, Eken A, Gülüm M, Erçil H, Ayyıldız A. Effect of obesity on International Prostate Symptom Score and prostate volume. Urol Ann. 2015;7(3):371-374. https://doi.org/10.4103/0974-7796.152056
  • Ponholzer A, Temml C, Wehrberger C, Marszalek M, Madersbacher S. The association between vascular risk factors and lower urinary tract symptoms in both sexes. Eur Urol. 2006; 50(3):581-586. https://doi.org/10.1016/j.eururo.2006.01.031
  • Lee JH, Kim SK, Lee DG. Associations of carotid artery plaque with lower urinary tract symptoms and erectile dysfunction. Int Urol Nephrol. 2014; 46(12):2263-2270. https://doi.org/10.1007/s11255-014-0830-y
  • Liu CC, Huang SP, Li WM, et al. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology. 2007; 70(4):677-680. https://doi.org/10.1016/j.urology.2007.05.025
  • Kim YD, Yang WJ, Song YS, Park YH. Correlation between prostate volume and metabolic or anthropometric factors in male visitors to a health promotion center. Korean J Urol. 2008; 49(2):139. https://doi.org/10.4111/kju.2008.49.2.139
  • Gachchi TN, Hanumegowda RK, Sundar J, Rammaiah K, Siddaiah MC. Comparison of prostate volume measured by transabdominal ultrasound and transrectal ultrasound in patient with LUTS due to benign prostatic enlargement. J Evid Based Med Healthc. 2017; 4(45):2748-2754. https://doi.org/10.18410/jebmh/2017/546
  • Hammarsten J, Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press. 1999;8(1):29-36. https://doi.org/10.1080/080370599438365
  • Nandeesha H. Benign prostatic hyperplasia: dietary and metabolic risk factors. Int Urol Nephrol. 2008; 40(3):649-656. https://doi.org/10.1007/s11255-008-9333-z
  • Hammarsten J, Högstedt B. Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer. Eur J Cancer. 2005; 41(18):2887-2895. https://doi.org/10.1016/j.ejca.2005.09.003
  • Parsons JK, Carter HB, Partin AW, et al. Metabolic factors associated with benign prostatic hyperplasia. J Clin Endocrinol Metab. 2006; 91(7):2562-2568. https://doi.org/10.1210/jc.2005-2799
  • Tang J, Li X, Wang N, et al. Correlation between hypoechoic nodules on ultrasonography and benign hyperplasia in the prostatic outer gland. J Ultrasound Med. 2005;24(4):483-488. https://doi.org/10.7863/jum.2005.24.4.483
  • Granneman R, Achari R, Hosmane B. PIII-60 pharmacokinetics and pharmacodynamics (PK/PD) of terazosin in hypertensive patients. Clin Pharmacol Ther. 1996;59(2):203-203. https://doi.org/10.1038/sj.clpt.1996.310
  • Nandeesha H, Koner BC, Dorairajan LN, Sen SK. Hyperinsulinemia and dyslipidemia in non-diabetic benign prostatic hyperplasia. Clin Chim Acta. 2006;370(1-2):89-93. https://doi.org/10.1016/j.cca.2006.01.019
  • Platz EA, Rimm EB, Kawachi I, et al. Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. Am J Epidemiol. 1999;149(2):106-115. https://doi.org/10.1093/oxfordjournals.aje.a009775
  • Erbay AR, Ede H, Zengin K, et al. Association of prostatic volume and carotid intima-media thickness in patients with benign prostatic hyperplasia. Urology. 2018;113:166-170. https://doi.org/10.1016/j.urology.2017.11.051
  • Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol. 1989;129(3):511-517. https://doi.org/10.1093/oxfordjournals.aje.a115162
  • Buttyan R, Chichester P, Stisser B, Matsumoto S, Ghafar MA, Levin RM. Acute intravesical infusion of a cobalt solution stimulates a hypoxia response, growth and angiogenesis in the rat bladder. J Urol. 2003;169(6):2402-2406. https://doi.org/10.1097/01.ju.0000058406.16931.93
  • Haust MD, Las Heras J, Harding PG. Fat-containing uterine smooth muscle cells in "toxemia": possible relevance to atherosclerosis? Science. 1977; 195(4284):1353-1354. https://doi.org/10.1126/science.841334
  • Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke. 1995;26(3):386-391. https://doi.org/10.1161/01.STR.26.3.386